Herlemann et al. showed that PSMA PET/CT was more accurate compared to CT in the nodal staging of prostate cancer, and Eiber et al. found that PSMA-PET/CT identified pathological involvement in additional regions in 24.6% of cases, compared to CT alone [7,8]. Here, FOLH1 is linked to prostate cancer.